Papers
6
Total Citations
114
H-Index
5
About
Kewang Nan is pioneering the frontier of ingestible robotics, creating revolutionary devices that operate inside the body without batteries. His research centers on developing soft, tissue-adhering robotic interfaces for gastrointestinal therapy, with a focus on non-invasive electrostimulation and controlled drug delivery. Nan's landmark 2024 work introduced the first ingestible, battery-free robotic interface capable of adhering to gut tissue for chronic electrostimulation—a breakthrough that overcomes critical limitations in electrode-tissue contact, dwell time, and power supply. This work has already garnered 45 citations, signaling its transformative potential for diagnosing and treating gastrointestinal disorders. He further advanced the field with theranostic gastrointestinal residence systems (25 citations) and soft robot-enabled controlled release of oral drug formulations (20 citations), demonstrating how shape-programming and locomotive soft robots can revolutionize pharmaceutical kinetics. Most recently, Nan developed a gastric retentive robotic capsule for emergency-prepared oral drug delivery, validated in canine models, showcasing his commitment to translating lab innovations into life-saving applications. With over 114 total citations and a trajectory of high-impact publications, Nan is establishing himself as a leading architect of next-generation ingestible medical devices.
Research Focus
Key Achievements
Top Papers
- 1
- 2Theranostic gastrointestinal residence systems25 citations · 2023
- 3Soft robot-enabled controlled release of oral drug formulations20 citations · 2023
- 4
- 5
- 6